Jun. 15, 2017

LEO Science & Tech Hub announce new collaboration to develop technology for minimally-invasive dermal biomarker assessment

LEO Science & Tech Hub today announced a two-year collaboration with the Karp Lab at Brigham and Women’s Hospital (BWH) to develop minimally-invasive technology to advance dermal biomarker assessment.

The Karp Lab, led by Jeffrey Karp, PhD, at BWH focuses on the development of platform technology and translational research to improve patient care. LEO Science & Tech Hub is an R&D innovation unit of LEO Pharma dedicated to identifying, developing, and funding innovative solutions that improve the lives of people with skin diseases.

LEO Science & Tech Hub and the Karp Lab will explore and develop technologies that could enable frequent and minimally-invasive assessment of relevant dermal biomarkers during clinical studies as well as the potential for diagnostic use in point-of-care testing. This kind of assessment could limit the number of painful skin biopsies patients must endure, and provide physicians with immediate feedback on how well a drug regimen is working.

Read more here.

News from the hub

Aug. 2017 23 LEO Science & Tech Hub Announces Collaborations with MGH Wellman Center for Photomedicine to Explore Imaging Technology and Develop Microbiopsy Device

The Hub today announced two collaborative projects with The Wellman Center for Photomedicine at Massachusetts General Hospital. The Hub will provide research funding to support development of novel imaging technology with the laboratory led by Conor L. Evans, Ph.D., Assistant Professor, Harvard Medical School, and a disposable microbiopsy device with Walfre Franco, Ph.D., Instructor, and […]

Read more
Aug. 2017 10 LEO Science & Tech Hub is a finalist for the Newcomer category of Xconomy Awards

We are honored to announce that LEO Science & Tech Hub is a finalist for the Newcomer category of Xconomy Awards.

Read more